@article {Lu:August 2005:0306-5251:218,
	author = "Lu, T. Y.-T.",
	author = "Kupa, A.",
	author = "Easterbrook, G.",
	author = "Mangoni, A. A.",
	title = "Profound weight loss associated with reboxetine use in a 44-year-old woman",
	journal = "British Journal of Clinical Pharmacology",
	volume = "60",
	year = "August 2005",
	abstract = "We report a case of significant weight loss experienced by a 44-year-old Caucasian woman treated with reboxetine. She was treated with this drug at 12 mg daily for a total duration of 11 months. During the corresponding period her body mass index (BMI) decreased from a baseline of 21.4 kg m<SUP>-2</SUP> to a low of 16.8 kg m<SUP>-2</SUP>. Withdrawal of the drug led to a full recovery of her BMI. The strongest evidence linking reboxetine to this woman's weight loss laid in the fact that the re-introduction of the drug subsequently caused a similar negative impact in her BMI.",
	pages = "218-220(3)",
	url = "http://www.ingentaconnect.com/content/bsc/bjcp/2005/00000060/00000002/art00014"
	doi = "doi:10.1111/j.1365-2125.2005.02407.x"
}